Bat Virus Receptor Studies Vital to Predict Spillover Risk
Latest work unexpectedly shows two close bat virus relatives of human respiratory virus MERS-CoV use bat ACE2 as cell entry ...
Tag: MERS-CoV
New Antiviral Compound Blocks SARS-CoV-2 From Entering Cells
Scientists at Washington University School of Medicine in St. Louis are collaborating with the NIH researchers to test the MM3122 ...
NBACC: Past Bioagent Research Informs Current and Future Pandemic Response
Like many U.S. research and development agencies, the Department of Homeland Security (DHS) Science and Technology Directorate (S&T) was forced to shift ...
NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates
With multiple promising SARS-CoV-2 vaccine candidates now under development, the National Institute of Allergy and Infectious Diseases (NIAID) is looking ...
SARS, MERS, COVID-19: Repurposing Drugs for a Pan-Coronavirus Treatment
A large international consortium of almost 200 researchers from 14 leading institutions in six countries has studied three different coronaviruses ...
Promising MERS Coronavirus Vaccine Trial in Humans
"The results of this vaccine trial are also important and promising with regard to the development of a vaccine against ...
Investigational Chimp Adenovirus MERS-CoV Vaccine Protects Monkeys
An investigational vaccine called ChAdOx1 MERS protected two groups of rhesus macaques from disease caused by Middle East respiratory syndrome ...
Senator Markey Introduces Legislation to Invest $1 Billion in Universal Coronavirus Vaccine
Senator Edward J. Markey (D-Mass.) today introduced legislation to conduct or support comprehensive research for the creation of a universal ...
Why It’s Important to Study Coronaviruses in African Bats
The current outbreak of a new coronavirus disease, named COVID-19, raises the question of where diseases like this come from ...
Emory, Collaborators Testing Antiviral Drug as Potential Treatment for Coronaviruses
The drug EIDD-1931 was effective against SARS and MERS viruses in the laboratory, and a modified version (EIDD-2801) could potentially ...
Remdesivir Prevents MERS Coronavirus Disease in Monkeys
The experimental antiviral remdesivir successfully prevented disease in rhesus macaques infected with Middle East respiratory syndrome coronavirus (MERS-CoV), according to ...
Steroids Could Do More Harm Than Good in Treating Coronavirus
Steroids should be avoided in the treatment of the current novel coronavirus, experts have advised. A commentary article published in The ...
Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus
Inovio Pharmaceuticals, Inc. today announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to ...
MERS Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai
Previous published serological studies showed that sera of Bactrian camels were all negative for MERS-CoV antibodies, suggesting that Bactrian camels ...
CEPI’s Richard Hatchett: Vaccines ‘Most Powerful Tool Against Infectious Diseases’
In May 2015, a 68-year-old South Korean man returning from the Middle East went to his doctor’s office with a ...
MERS-CoV: Novel Zoonotic Disease Outbreak a Hard Lesson for Healthcare
Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in 2012 and since then, sporadic but continued outbreaks have been ...
Inovio’s Positive First-in-Human MERS Vaccine Results Published in The Lancet Infectious Diseases
Inovio Pharmaceuticals, Inc. today announced that positive results from the first-in-human trial of its vaccine against the Middle East Respiratory ...
Adaptive Evolution of MERS-CoV to Infect Different Species
New research published in Cell Reports from scientists at the National Institute of Allergy and Infectious Diseases (NIAID) shows how ...
MERS-CoV: Clinical Trial Starts for Regeneron’s Monoclonal Antibody Treatments
Enrollment has begun in an early-stage clinical trial testing the safety of two human monoclonal antibodies (mAbs) designed to treat ...
Experimental MERS Antibody Therapeutics Enter Clinical Trial
Enrollment has begun in an early-stage clinical trial testing the safety of two human monoclonal antibodies (mAbs) designed to treat ...
